Business Description
Regencell Bioscience Holdings Ltd
NAICS : 325412
SIC : 2834
33-35 Leighton Road, 11/F First Commercial Building, Causeway Bay, Hong Kong, HKG
Description
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | N/A |
N/A
|
N/A
| |||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-EBITDA | -2.72 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0 | |||||
| Beneish M-Score | 0 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.71 | |||||
| 9-Day RSI | 46.81 | |||||
| 14-Day RSI | 45.8 | |||||
| 6-1 Month Momentum % | 3.82 | |||||
| 12-1 Month Momentum % | 401.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -108.62 | |||||
| ROA % | -62.77 | |||||
| ROIC % | -48.57 | |||||
| ROC (Joel Greenblatt) % | -72.99 | |||||
| ROCE % | -99.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 22 | |||||
| Price-to-Tangible-Book | 21.5 | |||||
| EV-to-EBIT | -317.75 | |||||
| EV-to-EBITDA | -323.84 | |||||
| EV-to-FCF | -514.84 | |||||
| Price-to-Net-Current-Asset-Value | 23.49 | |||||
| Earnings Yield (Greenblatt) % | -0.31 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:RGC
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0 | ||
| EPS (TTM) ($) | -0.37 | ||
| Beta | 0 | ||
| Volatility % | 296.68 | ||
| 14-Day RSI | 45.8 | ||
| 14-Day ATR ($) | 1.713047 | ||
| 20-Day SMA ($) | 32.041085 | ||
| 12-1 Month Momentum % | 401.91 | ||
| 52-Week Range ($) | 6 - 59 | ||
| Shares Outstanding (Mil) | 13.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Regencell Bioscience Holdings Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||